Send feedback

EVC2 p.Arg335Trp

c.1003C>T · rs148884226 · VCV1518821

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 3 submitters
AlphaMissense
likely benign
0.0901 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0233%, amr)
Missense predictors
0/2 damaging
AlphaMissense, SaProt · REVEL indeterminate
Conditions
2
Ellis-van Creveld syndrome

Computational evidence

Protein change
AlphaMissense0.0901likely benign
REVEL0.359indeterminate
SaProtLLR -7.61tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL is indeterminate.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP 1.5GERP -3, phastCons 0.002
Regional constrainto/e 1.14unconstrained · MANE · 146 kb · p 1.9e-08 · regional, not allelic
Overall
CADD20.9PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0233% Admixed American · 14/59,998 alleles
Filtering AF 0.0184% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0176%
Overall 0.0186% 301/1,613,952 alleles · ultra-rare exomes 278/1,461,826 · genomes 23/152,126 · joint denominator
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0272% 3,675
Admixed Americangrpmax 0.0233% 4,286
European (non-Finnish) 0.0206% 4,856
South Asian 0.0187% 5,357
Middle Eastern 0.0164% 6,084
African / African-American 0.0107% 9,363
Ashkenazi Jewishnot grpmax-eligible 0.00338% 29,604

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
EVC2
Protein
p.Arg335Trp
Coding
c.1003C>T
MANE Select
NM_147127
dbSNP
rs148884226
Type
single nucleotide variant
Location
chr4:5665517 (GRCh38)
Gene constraint
LOEUF 1.092 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure
AlphaFold pLDDT 73.33
Full EVC2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/evc2-p-arg335trp (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown